di-n-butyl-2,2-dichlorovinyl phosphate

Also Known As:

DBDCVP; di-1-butyl-2,2-dichlorovinyl phosphate; di-n-butyldichlorvos

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Polyneuropathies (Polyneuropathy) 10/01/1992 - "Single doses of certain organophosphates (OP), such as dibutyl-2,2-dichlorovinyl phosphate (DBDCVP) cause organophosphate-induced delayed polyneuropathy (OPIDP) in hens. "
2.	Peripheral Nervous System Diseases (PNS Diseases) 01/01/1988 - "Previous work in our laboratory indicated that di-n-butyl-2,2-dichlorovinyl phosphate (DBCV) produced electrophysiologic changes in hen peripheral nerve that coincided with the development of histopathologic changes and neurologic signs of peripheral neuropathy. "
3.	Neurologic Manifestations (Neurological Manifestations) 01/01/1988 - "Previous work in our laboratory indicated that di-n-butyl-2,2-dichlorovinyl phosphate (DBCV) produced electrophysiologic changes in hen peripheral nerve that coincided with the development of histopathologic changes and neurologic signs of peripheral neuropathy. "
4.	Ataxia (Dyssynergia) 01/07/1993 - "We report here that the resistance of chicks to single doses of neuropathic OPs is not absolute because ataxia was produced in 40-day-old chicks by 2,2-dichlorovinyl dibutyl phosphate (DBDCVP, 5.0 or 10.0 mg/kg s.c.) and by diisopropyl phosphorofluoridate (DFP, 2.0 mg/kg s.c.). "